DHEA decreases HIF-1α accumulation under hypoxia in human pulmonary artery cells: Potential role in the treatment of pulmonary arterial hypertension

Journal of Steroid Biochemistry and Molecular Biology

Volumn 109, Issue 1-2, 2008, Pages 81-89

  Dessouroux, A ^a   Akwa, Y ^a   Baulieu, E E ^a  

^a Universite Paris Sud   (France)

Author keywords

Deferroxamin; DHEA; HIF 1 ; Hypoxia; PAHT

Indexed keywords

3BETA METHYL DELTA5 ANDROSTEN 17 ONE; 7ALPHA HYDROXY PRASTERONE; ANDROSTENEDIOL; ANDROSTENEDIONE DERIVATIVE; DEFEROXAMINE; DELTA4 ANDROSTENE 3,17 DIONE; ESTRADIOL; HYPOXIA INDUCIBLE FACTOR 1; MESSENGER RNA; PRASTERONE; PRASTERONE SULFATE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; TESTOSTERONE; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; DRUG MECHANISM; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; PULMONARY HYPERTENSION; SMOOTH MUSCLE FIBER;

AMINO ACIDS, DICARBOXYLIC; ANOXIA; BASE SEQUENCE; CELLS, CULTURED; COBALT; DEFEROXAMINE; DEHYDROEPIANDROSTERONE; DNA PRIMERS; ENZYME INHIBITORS; ESTRADIOL; HUMANS; HYPERTENSION, PULMONARY; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IRON CHELATING AGENTS; MODELS, CARDIOVASCULAR; MYOCYTES, SMOOTH MUSCLE; PROCOLLAGEN-PROLINE DIOXYGENASE; PULMONARY ARTERY; TESTOSTERONE;

RATTUS;

EID: 40849102385     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2007.12.001     Document Type: Article

References (29)

1. Dawson C.A. Role of pulmonary vasomotion in physiology of the lung. Physiol. Rev. 64 2 (1984) 544-616
2. Rabinovitch M., Gamble W., Nadas A.S., Miettinen O.S., and Reid L. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am. J. Physiol. 236 6 (1979) H818-H827
3. Barbera J.A., Peinado V.I., and Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur. Respir. J. 21 5 (2003) 892-905
4. Tuder R.M., Chacon M., Alger L., Wang J., Taraseviciene-Stewart L., Kasahara Y., Cool C.D., Bishop A.E., Geraci M., Semenza G.L., Yacoub M., Polak J.M., and Voelkel N.F. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J. Pathol. 195 3 (2001) 367-374
5. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. U.S.A. 95 14 (1998) 7987-7992
6. Kallio P.J., Wilson W.J., O'Brien S., Makino Y., and Poellinger L. Regulation of the hypoxia-inducible transcription factor 1α by the ubiquitin-proteasome pathway. J. Biol. Chem. 274 10 (1999) 6519-6525
7. Salceda S., and Caro J. Hypoxia-inducible factor 1a (HIF-1a) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272 36 (1997) 22642-22647
8. Sutter C.H., Laughner E., and Semenza G.L. Hypoxia-inducible factor 1a protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc. Natl. Acad. Sci. U.S.A. 97 9 (2000) 4748-4753
9. 2 tension. Am. J. Physiol. 271 4 Pt 1 (1996) C1172-C1180
10. Yu A.Y., Frid M.G., Shimoda L.A., Wiener C.M., Stenmark K., and Semenza G.L. Temporal, spatial, and oxygen-regulated expression of hypoxia-inducible factor-1 in the lung. Am. J. Physiol. 275 4 Pt 1 (1998) L818-L826
11. Chun Y.S., Kim M.S., and Park J.W. Oxygen-dependent and -independent regulation of HIF-1α. J. Korean Med. Sci. 17 5 (2002) 581-588
12. Semenza G. Signal transduction to hypoxia-inducible factor 1. Biochem. Pharmacol. 64 5-6 (2002) 993-998
13. + channel of pulmonary arterial smooth muscle cells in pulmonary hypertensive rats. Zhonghua Jie He He Hu Xi Za Zhi 27 1 (2004) 41-45
14. Bonnet S., Dumas-de-La-Roque E., Begueret H., Marthan R., Fayon M., Dos Santos P., Savineau J.P., and Baulieu E.E. Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension. Proc. Natl. Acad. Sci. U.S.A. 100 16 (2003) 9488-9493
15. + channels of hypoxic human pulmonary vascular cells. Am. J. Respir. Cell Mol. Biol. 20 4 (1999) 737-745
16. + channel opener. Am. J. Physiol. 274 2 Pt 1 (1998) L186-L195
17. Burstein S., and Lieberman S. Hydrolysis of ketosteroid hydrogen sulfates by solvolysis procedures. J. Biol. Chem. 233 2 (1958) 331-335
18. Morfin R.F., Berthou F., Floch H.H., Vena R.L., and Ofner P. Evaluation of the specific activity of biochemically-prepared carrier-crystallized androgen radiometabolites by a new procedure. J. Steroid Biochem. 4 4 (1973) 381-391
19. Sharp F.R., and Bernaudin M. HIF1 and oxygen sensing in the brain. Nat. Rev. Neurosci. 5 (2004) 437-448
20. Escuin D., Kline E.R., and Giannakakou P. Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1α accumulation and activity by disrupting microtubule function. Cancer Res. 65 19 (2005) 9021-9028
21. 2 tension. Proc. Natl. Acad. Sci. U.S.A. 92 12 (1995) 5510-5514
22. 2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3 4 (2003) 363-375
23. Ricker J.L., Chen Z., Yang X.P., Pribluda V.S., Swartz G.M., and Van Waes C. 2-Methoxyestradiol inhibits hypoxia-inducible factor 1α, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma. Clin. Cancer Res. 10 24 (2004) 8665-8673
24. Mukundan H., Kanagy N.L., and Resta T.C. 17β-Estradiol attenuates hypoxic induction of HIF-1α and erythropoietin in Hep3B cells. J. Cardiovasc. Pharmacol. 44 1 (2004) 93-100
25. DePasquale J.A. Rearrangement of the F-actin cytoskeleton in estradiol-treated MCF-7 breast carcinoma cells. Histochem. Cell Biol. 112 5 (1999) 341-350
26. Varet J., Vincent L., Akwa Y., Mirshahi P., Lahary A., Legrand E., Opolon P., Mishal Z., Baulieu E.E., Soria J., Soria C., and Li H. Dose-dependent effect of dehydroepiandrosterone, but not of its sulphate ester, on angiogenesis. Eur. J. Pharmacol. 502 1-2 (2004) 21-30
27. Simoncini T., Mannella P., Fornari L., Varone G., Caruso A., and Genazzani A.R. Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology 144 8 (2003) 3449-3455
28. Liu D., and Dillon J.S. Dehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptor. Steroids 69 4 (2004) 279-289
29. Liu D., and Dillon J.S. Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Gαi2,3. J. Biol. Chem. 277 24 (2002) 21379-21388